Objective: To identify and review available evidence on the diagnostic yield of brain computed tomographies (CTs) and magnetic resonance images (MRIs) in first-episode psychosis, and examine yield in our own institution (Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec).
I n the diagnostic assessment of new-onset psychotic symptoms, it is essential to exclude the uncommon possibility they may be caused by a neurological illness, especially one that could respond to treatment quite different from that provided for psychiatric conditions. Is brain imaging necessary for this purpose? When CT and then MRI techniques became common, researchers started investigating their usefulness in clinical psychiatry. [1] [2] [3] [4] [5] [6] [7] [8] Weinberger 9 was among the first in 1984 to propose a list of indications for brain CT scanning, including FEP-a broad term that includes a diverse group of patients, usually adolescents or young adults who, for the first time, manifest psychotic symptoms suggestive of schizophrenia, related psychoses, or affective disorders, but excludes cases of delirium. Weinberger justified this recommendation based on numerous rare brain illnesses that occasionally appear with psychosis: Huntington disease, Wilson disease, systemic lupus erythematosus, metachromatic leucodystrophy, and encephalitis. It had already been noted that illnesses affecting specific regions of the brain could cause psychotic, schizophrenia-like states, with the temporal lobe, diencephalon, and basal ganglia being the more likely areas. 10, 11 Other authors also mention a rare association between demyelinating diseases and psychosis, generally when the condition is well entrenched but occasionally in the early stages. 12 Weinberger's early recommendation on the use of CT scans in FEP has found its way into many often quoted practice guidelines and textbooks, some unequivocal, 13, 14 others acknowledging controversy or need for clinical judgement. 15, 16 However, the emphasis has shifted: imaging is seen not only to exclude possible causal neurological illness but also perhaps to help confirm diagnosis and prognosis of schizophrenia. Thus the Canadian Psychiatric Association guidelines recommend using brain imaging for a first episode, mentioning the more common abnormality as nonspecific enlargement of ventricles and cortical fissures, found in up to 30% to 40% of schizophrenia patients. 14 The American Psychiatric Association guidelines recommend using brain imaging, preferably MRI, for FEP, adding that the finding of ventricular enlargement or diminished cortical volume "may enhance confidence in the diagnosis (of schizophrenia) and provide information relevant to treatment planning and prognosis." 15, p 23 Indeed, MRI studies have demonstrated that the brains of people suffering from schizophrenia differ from control subjects: whole brain volume reduction, lateral and third ventricle enlargement, atrophy of medial and neocortical temporal lobes, and subcortical anomalies such as cavum septi pellucidi and basal ganglia enlargement are among the most commonly described. 17 These anomalies are often present at disease onset, with some evidence of progression over time. 18 Rather small and subtle, close to the limit of detection by MRI methods, 18 these findings are based on aggregated, rather than individual, measurements and require more precise computerized measuring methods than those provided by clinical radiological interpretation. While they tend to confirm schizophrenia's neurobiological aetiology, use for diagnostic or prognostic purposes 15 seems premature: to our knowledge, no studies have shown that findings are sensitive and (or) specific enough to be used as clinical markers.
CT scans are ubiquitous nowadays and take little time, making them the technique of choice in emergency settings. 19 They deliver radiation doses much greater than conventional X-rays; the lifetime risk of cancer from one brain CT scan is small, but worse in younger age groups (in the vicinity of 1:10 000 for a 15-to 20-year-old). 20 While MRI carries no risk of radiation exposure, it is not yet widely available, especially in smaller urban and rural areas; the exposure to a powerful magnetic field makes this technique unsuitable for people with metallic foreign objects in or on their bodies. 19 MRI provides better spatial resolution, grey-white matter differentiation, and white matter anomaly detection than CT. 19 Because it takes longer and exposes people to a tight, confined, and noisy space, MRI is known to generate anxiety, sometimes severe enough to interfere with the performance of the test. 19, 21 Use entails costs. Currently our institution charges $243 for a head CT scan and $430 for a head MRI.
How useful are these tests in assessing FEP? How many exams are required to find a possible causal neurological condition (diagnostic yield) or, better, one significantly modified clinical outcome? Is it possible to diagnose these same conditions using simpler, less expensive methods? The issue of fortuitous findings must be examined: when used for routine screening, these examinations may display abnormalities unrelated to the psychosis that will require further exams and consultations with no added benefit, not to mention unnecessary worries in an already vulnerable population.
Our intention was to review and analyze available evidence on the usefulness of brain imaging (CT and MRI) in FEP, as well as examine the diagnostic yield of these examinations in our own institution.
Methods
We searched the following databases: MEDLINE (1966 to October 2007) and EMBASE (1980 to October 2007). The main key words used were: first psychosis, psychiatry, schizophrenia, radiology, tomodensitometry, and magnetic resonance. Bibliographies of relevant articles were handsearched for other useful publications. We included studies that were either prospective or retrospective in which at least one group was clearly identified as FEP, where the mean age was 35 years or younger, and where individual MRI or CT brain findings were provided in detail. We excluded studies of brain morphological changes in psychosis (volumetric measurements such as cortical thickness). We reviewed radiological findings, first individually, then by consensus panel (1 neurologist, 1 psychiatrist, and 2 psychiatric residents) and classified the results in the following manner:
1. Normal.
Abnormal, with no clinical impact: benign or
nonspecific findings with no implication on diagnosis, management, or treatment. We included in this category all findings such as atrophy, fissure enlargement, benign cysts, and other similar matters.
3. Abnormal, with implication on management or treatment, but an unlikely causal link to psychotic symptoms. This group included findings warranting neurological investigation or treatment, such as the unexpected finding of an arterio-venous malformation, but with a high unlikelihood that treatment would influence the course of the psychosis.
4. Abnormal, with implication on management or treatment, and a possible causal link to psychotic symptoms. This group included the neurological syndromes mentioned by Weinberger, 9 lesions in key cerebral regions already mentioned (temporal lobes, diencephalon, and basal ganglia), 10, 11 and demyelinating diseases. 12 Only group 4 findings were used in calculating yield; given that group 3 findings are clinically important (although probably as likely to be found in otherwise healthy subjects), results of combining these 2 groups are provided.
We also conducted an audit of all brain imaging studies requested for patients hospitalized on our own psychiatric wards (Centre Hospitalier Universitaire de Sherbrooke) between April 1, 2001, and July 31, 2006. As per Quebec audit rules, hospital management authorized examination of charts and waived the requirement for informed consent. A total of 425 brain imaging studies were performed. Of this number, the reason for examination was stated as FEP in 46 patients aged 50 years and younger. Demographic characteristics and final diagnoses were recorded. Radiological interpretations were classified using the 4 categories previously described.
Results

Review of Published Evidence
Five studies met our inclusion criteria. Clinical characteristics of samples are described in Table 1 and radiological findings are provided in Table 2 .
In 1988, Battaglia and Spector 22 prospectively obtained standard CT scans in a consecutive series of 45 admitted FEP patients. Three patients displayed neurological anomalies on physical exam (one each of hypereflexia of right lower limb, Babinski's sign with right-sided hyperreflexia, and left-gaze diplopia). Forty-two scans were interpreted as normal, including the 3 of patients showing neurological signs. Three were deemed abnormal. The first showed mild atrophy, a nonspecific finding. The second displayed a possible frontal white matter infarct and mild atrophy, a finding where a causal link is only remotely plausible, but one that might have impacted management (see Discussion). The third, a 21-year-old man, showed a possible left caudate infarct, which we deemed as possibly causal. The authors provided no data as to how the findings might have modified management or treatment.
In 1994, Gewirtz et al 23 put together a retrospective series of 168 FEP patients who had undergone CT scans. These were not consecutive: many admitted FEP subjects had not been scanned for various reasons. This was an older cohort, with subjects aged up to 66 years. Findings by a first radiologist were blindly reviewed by a second; in cases of disagreement, findings were excluded. Atrophy was noted in 40% of cases. We deemed 4 findings to be possibly related to psychosis:
1. One subject with a moderate-to-large arachnoid cyst in the temporal region (43-year-old man). These cysts are usually benign developmental anomalies, but when large can cause epileptic discharges or compression signs and symptoms. In this case, the large size and temporal location may have contributed to the psychosis. Some subjects had more than one anomaly, which explains why adding findings in each study may result in totals slightly larger than the number of subjects. Percentages by, however, express proportion of subjects, not a proportion of all findings. a Arachnoid cyst classified here because original authors recommended urgent opinion for this finding. It is usually considered a benign developmental anomaly unless very large.
abuse were excluded. The control subjects are said to have come from similar sociodemographic areas. The percentage of abnormal MRIs was similar, with 32/152 (21.2%) in the FEP group and 23/98 (23.5%) in the control group. Thirteen (8%) in the FEP group, compared with 5 (5.1%) in the control group, were thought to need referral and review by the treating physician. We classified 2 possible cases of demyelinating diseases in the FEP group as possibly causal (although one such case was also noted in the control group). One case of possible Huntington disease was noted in the FEP group, a diagnosis the authors say was not confirmed. No other data are available on the implication of findings on diagnosis or treatment.
In 2006, in the context of a clinic for early detection of psychosis, Borgwardt et al 26 identified a group of 76 patients meeting criteria for FEP. Among the 36 invited to have an MRI scan, 30 agreed. Thus the series appears to be prospective but not consecutive. They were compared with a group of 37 people considered at high risk for schizophrenia, a group of 17 depressive control subjects, and a group of 26 healthy control subjects (total in study: 110). Among this total, 31 (28%) had anomalies that were referred for further neurological evaluation, with none resulting in a neurological diagnosis or medical intervention. A case of right temporal hamartoma was noted in the FEP group, but neither we nor the original authors considered this finding causal (these are usually asymptomatic). The prevalence of anomalies was somewhat higher in FEP and at-risk groups, compared with healthy control subjects (P < 0.05), but numbers were small.
Our Own Retrospective Series
Of the 46 imaging studies done in a context of FEP, CT accounted for 44 and MRI for 2. All were normal except one CT displaying a small lipoma above the pineal gland, a fortuitous finding with no implication on diagnosis or management (Table 3) .
Summary
Combining results gives a total of 384 CT scans. We classified 5 (1.3%) findings as possibly causal. Thus 77 exams were required to yield one possibly positive finding with an expenditure of $18 711 per finding. We classified 4 (1%) as possibly modifying management or justify further investigation, but unlikely to be causal. MRI scans totalled 184. Two (1.1%) revealed possibly causal findings; thus 98 exams were required to yield one possibly positive finding with an expenditure of $39 560 per finding. We classified 12 (6.5%) as showing anomalies that could modify management or justify further investigation, but unlikely to be causal. Groups 3 and 4 thus represent 7.6%. Thirty-one (16.8%) were classified as benign or nonspecific anomalies.
Discussion
The main function of cerebral imaging in FEP is to identify possibly causal, otherwise unsuspected neurological illnesses that may require different treatment. These appear to be rare, judging by our analysis of other studies and of our own data. Is our reanalysis and reclassification of previously published data valid? There is indeed room for information bias as written reports do not compare with re-examining the original radiological findings. We tried to deal with this by classifying findings first individually and then by group consensus, including input from a senior neurologist. Ultimately, a component of clinical judgment was inevitable. When in doubt as to the causal nature of findings, we chose to err on the side of caution and include them.
Did we include all relevant studies? We carefully checked major databases and hand-searched references; such cross-referencing made the omission of any significant study unlikely.
None of the studies chose patients randomly; many, including our own, did not choose patients consecutively, which leaves results open to selection bias, likely in the direction of overestimation of yield. Combining results from various studies (with slightly different populations and inclusion criteria) induces uncertainty about the point estimates we have calculated. The diagnostic yield calculated, even though small, is likely to be an overestimation of the clinical usefulness of the findings. Whether these made a significant difference in patient management and outcome is largely unknown. These patients likely were treated using conventional psychotropic interventions. Three of 5 possibly causal cases on CT scans were of vascular origin, [22] [23] where the intervention might have been modified by complementing the antipsychotic regimen with a search for treatable causes of abnormal coagulation, possibly an anticoagulant such as acetylsalicylic acid and treatment of vascular risk factors. In 2 of the 3 cases, patients were aged 50 years and older. 23 The 2 other possible cases were benign cystic masses, one of which was judged symptomatic and required surgery 23 ; this person likely had clinical signs and symptoms that could have signalled the problem prior to imaging. MRI identified 2 cases of possible demyelinating disease. 25 The causal link to psychosis is probably weak, psychotic manifestations of these illnesses generally appearing late in the evolution of the disease. 12 Further, it is unlikely that clinicians would decide to initiate treatment for a possible demyelinating disease merely on the basis of an MRI finding, with no obvious neurological signs. 19 None of the 568 brain imaging studies found any of the illnesses for which Weinberger 9 made his initial recommendation. This is not surprising, for they are quite rare (estimated prevalence: 7 to 15:100 000 for Huntington disease; 4:100 000 for Wilson disease; 50:100 000 for systemic lupus erythematosus; and 0.0016:100 000 for metachromatic leucodystrophy), 27 making the probability that they would be found by a screening test infinitesimal. 28 Further, adequate history taking, physical examination, and simple inexpensive blood tests likely permit detection prior to any brain imaging, with greater diagnostic sensitivity and specificity (antinuclear antibodies for systemic lupus, liver enzymes and plasma ceruloplasmin for Wilson disease). 27 Family history is likely to be positive in Huntington disease, an autosomal dominant condition. Signs of hepatic involvement are common in Wilson disease, as are skin, renal, rhumatological, and other inflammatory findings in systemic lupus or other vasculitis. Finally, these conditions often display easily detectable extrapyramidal movement disorders. 27 As brain imaging is not the most sensitive or specific method for diagnosing these conditions, a negative test may lull the clinician into a false sense of security. Lastly, of these rare illnesses, only Wilson disease and systemic lupus are likely to respond to a specific treatment where diagnostic delay could have serious consequences. The others are degenerative, with no specific treatment available to this day. Thus we conclude that Weinberger's recommendation 9 must be considered wrong. The same can be said of more recent practice guidelines. [13] [14] [15] The low yield demonstrated in the studies included is in keeping with findings from other authors. Adams et al 29 With broader psychiatric populations, yield has also been quite low: CT scanning yielded no potentially causal lesion in a sample of 397 patients without neurological focal signs, 241 of which were psychotic 31 ; and routine use of CT scanning in a sample of 261 psychiatric inpatients with no focal neurological signs (142 suffering from schizophrenia or delusional disorder) was fruitless. 32 Larson et al 33 examined a sample of 123 psychiatric inpatients in which CT scans had been used as a screening procedure. They conclude that this was costly and inefficient; all 6 true positive patients in their sample had clear neurological signs on examination, a finding that highlights the usefulness of neurological examination on admission 33 ; 5 of these 6 patients were aged 50 years and older. A vast study examined 6200 consecutive MRI scans of psychiatric inpatients (40% of all admissions during the 5-year study period); the number of unanticipated, possibly remediable findings was low (1.6%), the most common being white matter abnormalities (suggesting possible multiple sclerosis) and haemorrhage (0.4% each). 34 Our review demonstrates that in FEP, brain imaging will display mostly benign and nonspecific findings. Many of these are probably related to the psychosis, as morphological studies have demonstrated, 17, 18 but have little practical impact on diagnosis or treatment.
Neuroimaging generates false-positive and (or) incidental findings. This possibility is increased by the rarity of true-positive findings. This is the case with MRI in particular. In Lubman et al's study, 25 these findings appeared common and equally distributed between FEP subjects and healthy control subjects. In Borgwartz et al, 26 almost one-third of all study patients, including healthy control subjects, were referred for further neurological investigation; nothing came of this. In a study of 1000 healthy volunteers submitted to brain MRI, 2.9% needed referral for anomalous findings. 35 This represents extra costs and a burden on neurological services, along with largely unnecessary worries and expenditures for patients.
Conclusion
Are further studies required to clarify this issue? Published studies often have been retrospective and generally have provided little data as to the diagnostic utility and clinical consequences of the findings. It would still seem relevant to devise a prospective before-after study, 36 with a baseline clinical assessment followed by imaging, then reassessment. Such a study would probably require several hundred patients, given the relative rarity of true-positive findings. The study should attempt to classify findings in 4 groups, with definitions similar to the ones used here. As in Larson et al, 33 the study should go beyond imaging findings and detail ensuing diagnostic or therapeutic actions, along with impact on overall patient health. One might, from this information, calculate an effort-yield ratio (how many tests were required to yield one positive outcome) and the percentage of false positives (findings justifying more diagnostic procedures or examinations, but ultimately fruitless).
Until such time, we conclude that evidence to date indicates that routine brain imaging in FEP is unnecessary and costly. The true screening procedure is conventional history-taking, mental status, and neurological examination, the latter an often neglected aspect of psychiatric admission procedures. 37 Neuroimaging cannot replace these basic methods. When neurological signs or symptoms accompany the psychosis, when the history is positive for neurological illnesses or trauma, when the psychosis is atypical or suggestive of delirium (clouded sensorium, disorientation, memory loss, and [or] visual hallucinations), or when the patient is aged 50 years and older, imaging may complement clinical acumen more usefully. Conclusions : Dans le premier épisode psychotique, les images de routine par TDM ou IRM présentent peu d'avantages et devraient être réservées aux situations où les antécédents ou l'examen suggèrent une cause neurologique, ou peut-être pour les personnes de plus de 50 ans.
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